The development of an anticancer immune response is often precluded by an immunosuppressive microenvironment, which can be created by the presence of large numbers of regulatory T cells (Treg). The findings of research using a mouse model of melanoma demonstrate the importance of neuropilin-1 (Nrp1) to Treg-mediated immunosuppression: Nrp1−/− Treg were found to enhance antitumour immunity, often resulting in tumour clearance. However, only a proportion of Nrp1−/− Treg were required for this effect. These enhanced antitumour effects were found to be mediated by IFNγ release from Nrp1−/− Treg. Further investigations revealed that IFNγ-induced Treg fragility is required for a response to anti-programmed cell death protein 1 antibodies in mice, thus highlighting the central role of Treg in the generation and maintenance of an immunosuppressed tumour microenvironment.